Wind turbine producer Goldwind returned and 36Kr Fund also invested as Tsinghua's rocket technology developer LandSpace secured $43.2m in a series B-plus round.
Inflammatory disease drug developer Inflazome, based on research at University of Queensland and Trinity College Dublin, has added $45.6m in series B capital to its coffers.
Online higher education platform Unicaf has raised series B funding from a consortium also including Goldman Sachs, EdX and CDC Group as it gears up to target more students.
The funding from crowdfunding platform SyndicateRoom is part of a wider series B round for Manchester gel therapy developer Gelmetix and adds to approximately $1.3m raised in 2014 and 2015.
Boehringer Ingelheim and Helsinn helped University of Geneva vaccine spinout Amal reach the second close of a series B round that now totals $32.7m.
Memory technology supplier and New York University spinout Spin Memory has secured $52m in a round featuring Applied Ventures and Arm.
Osaka University and Kyoto Institute of Polymer Science have both put money behind automated patent investigation platform Gold IP, taking its funding to $4.6m altogether.
UniServices has committed $2m to a targeted $20m series B round through the Inventors Fund, with investors also including Daimler Financial Services.
The George Washington spinout had previously raised $4.1m in equity for its low-voltage implantable cardiac defibrillator.
Satellite launching rocket producer Gilmour Space Technologies has been backed by Main Sequence Ventures, managers of Csiro Innovation Fund, taking its total to $17.4m.